Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (3y) (2016 - 2025)
Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 46.78% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 66.14% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -39.73% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 296.32% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -53.57% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -246.81% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.84% |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,654.25% |
| Dec 31, 2024 | 692.44% |
| Sep 30, 2024 | 832.17% |
| Mar 31, 2024 | -2,965.63% |
| Dec 31, 2022 | -27.20% |
| Dec 31, 2021 | 57.88% |
| Sep 30, 2021 | 0.00% |
| Dec 31, 2020 | -31.36% |
| Dec 31, 2019 | 101.45% |
| Sep 30, 2019 | 505.96% |
| Jun 30, 2019 | -81.71% |
| Mar 31, 2019 | 19.26% |
| Dec 31, 2018 | -76.26% |
| Sep 30, 2018 | 84.16% |
| Mar 31, 2017 | -44.22% |
| Dec 31, 2016 | -293.38% |